References
- Aron AM, Freeman JM, Carter S. The natural history of Sydenham's chorea: review of the literature and long-term evaluation with emphasis on cardiac sequelae. Am J Med 1965; 38: 83–95
- Breutsch W. Late cerebral sequlae of rheumatic fever. Arch Intern Med 1994; 73: 472–482
- Genel F, Arslanoglu S, Uran N, Saylan B. Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev 2002; 24: 73–76
- Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry M. Postnatal development profile brain–derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002; 328: 261–264
- Lal S, Allen J, Etienne P. Dopaminergic function in Gilles de la Tourette's syndrome, Sydenham's chorea and torsion dystonia. Clin Neurol Neurosurg 1976; 79: 66–69
- Lang UE, Hellweg R, Seifert F, Schbert F, Gallinat J. Correlation between serum brain-derived neurotrophic factor level and in vivo marker of cortical integrity. Biol Psychiatry 2007; 62: 530–535
- Moore DP. Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. J Clin Psychiatry 1996; 57: 407–414
- Naidu S, Narasimachari N. Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially. Ann Neurol 1980; 8: 445–447
- Pan W, Banks WA, Fasold MB, Blush J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998; 37: 1553–1561
- Pena J, Mora E, Cardozo J, Molina O, Cecilia M. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up 18 patients. Arq Neuropsiquiatr 2002; 60: 374–377
- Spissu A, Corsini GU, Marrosu F. Treatment of Sydenham's chorea with a combination of l-dopa and a peripheral dopa decarboxylase inhibitor. Psychopharmacologia 1975; 44: 311–312
- Teixeira AL, Jr, Cardoso F, Maia DP, Cunningham MC. Sydenham chorea may be a risk factor for drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2003; 74: 1350–1351
- Teixeira AL, Jr, Maia DP, Cardoso F. Psychosis following acute Sydenham's chorea. Eur Child Adolesc Psychiatry 2007; 16: 67–69
- Yoshimura R, Hori H, Sugita A, Ueda N, Kakihara S, Umene W, et al. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxyphenylglycol (MHPG), but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1072–1077
- Yoshimura R, Nakano Y, Hori H, Ikenouchi A, Ueda N, Nakamura J. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Hum Psychopharmacol 2006; 21: 433–438
- Yoshimura R, Nakamura J, Shinkai K, et al. An open study of risperidone liquid in the acute phase of schizophrenia. Hum Psychopharmacol 2005; 20: 243–248
- Yoshimura R, Nakamura J, Shinkai K, Ueda N. Clinical response to antidepressants treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 611–616